000 01849 a2200529 4500
005 20250514155044.0
264 0 _c20031106
008 200311s 0 0 eng d
022 _a0008-5472
040 _aNLM
_beng
_cNLM
100 1 _avan Ojik, Heidi H
245 0 0 _aCpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
_h[electronic resource]
260 _bCancer research
_cSep 2003
300 _a5595-600 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bispecific
_ximmunology
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntibody-Dependent Cell Cytotoxicity
_xdrug effects
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCpG Islands
_ximmunology
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aGranulocytes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aImmunization, Passive
_xmethods
650 0 4 _aImmunoglobulin G
_ximmunology
650 0 4 _aKiller Cells, Natural
_xdrug effects
650 0 4 _aLymphoma
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Inbred C3H
650 0 4 _aMice, Inbred C57BL
650 0 4 _aOligonucleotides
_ximmunology
650 0 4 _aReceptor, ErbB-2
_ximmunology
650 0 4 _aReceptors, IgG
_xbiosynthesis
650 0 4 _aUp-Regulation
700 1 _aBevaart, Lisette
700 1 _aDahle, Christopher E
700 1 _aBakker, Annie
700 1 _aJansen, Marco J H
700 1 _avan Vugt, Martine J
700 1 _avan de Winkel, Jan G J
700 1 _aWeiner, George J
773 0 _tCancer research
_gvol. 63
_gno. 17
_gp. 5595-600
999 _c14261776
_d14261776